Table 1.
Haematological malignancies | IFI | Sera tested / value detected | Sera tested / value detected | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
GAL | BGD | ||||||||||
1st week | 2nd week | 3rd week | 4th week | SD | 1st week | 2nd week | 3rd week | 4th week | SD | ||
Proven IA | |||||||||||
AML | patient 7 | 0.503* | 1.054 | 0,577 | 0,456 | 608,228985 | 324* | 274 | 176 | 7 | 135,06418 |
AML | patient 4 | 0,98 | 1,068 | 0,807* | 0.503 | 0,50819372 | 171 | 180 | 66* | 7 | 122,32947 |
AML | Patient 24 | 0.06 | 0.133* | 0.06 | 0.274 | 0,13160043 | 186 | 70* | 65 | 54 | 7,7781746 |
Proven IC | |||||||||||
ABMT | patient 1 | 0,535 | 0,77* | 1 | 2 | 0,70710678 | 109 | 53* | 83 | 85 | 1,4142136 |
AML | patient 6 | 0,3 | 0,766 | 1,219* | 0.423 | 0,33393118 | 214 | 301 | 387* | 159 | 100,40916 |
AML | patient 13 | 0.554* | 0,545 | 0.389 | 0.152 | 0,22201641 | 89* | 114 | 62 | <7 | 36,769553 |
Probable IA | |||||||||||
ABMT | patient 3 | 0,863 | 0,732 | 0.766 | 0.4 | 0,37678567 | 338 | 141 | 37 | 7 | 70,323064 |
AML | patient 8 | 0,514 | 0,77 | 0,429 | 0.084 | 0,24112341 | 116 | 28 | 7 | 7 | 12,124356 |
AML | Patient 5 | 0.766 | 0.5 | 0.501 | - | 0,243559 | 214 | 266 | 85 | - | 127,98633 |
NHL | patient 9 | 0,599 | 0,8 | 0.514 | - | 0,31328759 | 109 | 103 | 11 | - | 65,053824 |
NHL | patient 10 | 0,814 | 0,611 | 1,229 | - | 0,43699199 | 152 | 249 | 287 | - | 26,870058 |
AML | patient 2 | 0,637 | 0,538 | 1,005 | 0.736 | 0,27771035 | 147 | 523 | 159 | 47 | 248,86944 |
AML | patient 11 | 0,460 | 0,617 | 0.06 | - | 0,43333861 | 408 | 171 | 43 | - | 90,509668 |
AML | patient 12 | 0,410 | 0,41 | 0.098 | 0.06 | 0,2869675 | 532 | 71 | 52 | 20 | 25,774665 |
AML | patient 14 | 0,051 | 0,887 | 0.599 | 0.2 | 0,44310524 | 199 | 66 | 59 | 7 | 32,233523 |
AML | patient 15 | 0,66 | 0,62 | 0,06 | 0,3959798 | 146 | 186 | 54 | 93,338095 | ||
AML | patient 16 | 0,587 | 0.288 | 0.204 | 0.553 | 0,12649632 | 82 | 83 | 124 | 161 | 39,01709 |
AML | patient 17 | 0,767 | 0.056 | 0.118 | 0.179 | 0,02995383 | 84 | 82 | 77 | 61 | 10,969655 |
AML | patient 18 | 0,859 | 0.404 | 0.125 | 0.026 | 0,13700194 | 124 | 70 | 56 | 62 | 7,0237692 |
ABMT | patient 19 | 0,583 | 0.278 | 0.474 | 0.11 | 0,16139273 | 394 | 388 | 301 | 287 | 54,720502 |
MM | patient 20 | 1,172 | 0,523 | 0,06 | - | 0,32739044 | 114 | 62 | <7 | - | 38,890873 |
AML | patient 21 | 0,913 | 0,424 | 0,233 | - | 0,1350574 | 523 | 7 | 7 | - | 297.91 |
MM | patient 22 | 0,613 | 0,5 | 0,3 | - | 0,14142136 | 180 | 24 | <7 | - | 12,020815 |
AML | patient 23 | 0,859 | 0,5 | 0,423 | - | 0,05444722 | 124 | 79 | 70 | - | 6,363961 |
Legend for Table 1:
indicate the time of positive culture for Aspergillus/Candida
AML: acute myeloid leukemia; NHL: non-Hodgkin’s lymphoma; ABMT: autologous bone marrow transplant; MM: multiple myeloma
SD: standard deviation